We have demonstrated that BRD4 positivity (Allred score of 6 or higher) is significantly associated with T-bet+ TILs, which are a subset of T cells that we have previously determined to be associated with a good outcome in breast cancer patients, despite being associated with adverse clinicopathological features. This evidence concerns the gene BRD4 and breast cancer.